GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Price, Quote, News and Overview
OSL:GENT - Euronext Oslo - NO0010748866 - Common Stock - Currency: NOK
GENT.OL Quote, Performance and Key Statistics
OSL:GENT (5/2/2025, 7:00:00 PM)
49.9
+2.9 (+6.17%)
The current stock price of GENT.OL is 49.9 NOK. In the past month the price increased by 6.62%. In the past year, price increased by 29.27%.
GENT.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL.PA | ESSILORLUXOTTICA | 37.92 | 117.81B | ||
| 1EL.MI | ESSILORLUXOTTICA | 37.91 | 117.76B | ||
| ESL.DE | ESSILORLUXOTTICA | 37.75 | 117.26B | ||
| CBHD.DE | COLOPLAST-B | 31.95 | 19.75B | ||
| GBT.PA | GUERBET | 15.73 | 252.55M | ||
| PTP.DE | PENTIXAPHARM HOLDING AG | N/A | 73.41M | ||
| AFME.PA | AFFLUENT MEDICAL SA | N/A | 51.16M | ||
| ALCJ.PA | CROSSJECT | N/A | 46.23M | ||
| IVN.MI | IVISION TECH SPA | N/A | 19.03M |
Related stock screener links
About GENT.OL
Company Profile
Gentian Diagnostics ASA engages in the research, development, production, marketing, and distribution of immunoassays. The company is headquartered in Moss, Ostfold and currently employs 63 full-time employees. The company went IPO on 2016-12-14. The firm develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company’s product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The firm is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.
Company Info
GENTIAN DIAGNOSTICS ASA
Bjornasveien 5
Moss OSTFOLD NO
Employees: 58
Phone: 4799339905
GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ
What is the stock price of GENTIAN DIAGNOSTICS ASA today?
The current stock price of GENT.OL is 49.9 NOK. The price increased by 6.17% in the last trading session.
What is the ticker symbol for GENTIAN DIAGNOSTICS ASA stock?
The exchange symbol of GENTIAN DIAGNOSTICS ASA is GENT and it is listed on the Euronext Oslo exchange.
On which exchange is GENT.OL stock listed?
GENT.OL stock is listed on the Euronext Oslo exchange.
What is the price forecast or stock price prediction for GENTIAN DIAGNOSTICS ASA stock?
7 analysts have analysed GENT.OL and the average price target is 68.34 NOK. This implies a price increase of 36.95% is expected in the next year compared to the current price of 49.9. Check the GENTIAN DIAGNOSTICS ASA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GENTIAN DIAGNOSTICS ASA worth?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a market capitalization of 769.46M NOK. This makes GENT.OL a Small Cap stock.
How many employees does GENTIAN DIAGNOSTICS ASA have?
GENTIAN DIAGNOSTICS ASA (GENT.OL) currently has 58 employees.
What are the support and resistance levels for GENTIAN DIAGNOSTICS ASA (GENT.OL) stock?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a support level at 49.42 and a resistance level at 50. Check the full technical report for a detailed analysis of GENT.OL support and resistance levels.
Is GENTIAN DIAGNOSTICS ASA (GENT.OL) expected to grow?
The Revenue of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 33.11% in the next year. Check the estimates tab for more information on the GENT.OL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GENTIAN DIAGNOSTICS ASA (GENT.OL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GENT.OL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GENT.OL, evaluating the profitability, health, valuation and growth aspects
- GENTIAN DIAGNOSTICS ASA (GENT.OL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GENTIAN DIAGNOSTICS ASA (GENT.OL) Sales and EPS estimates to see what analysts future expectations are.
- GENTIAN DIAGNOSTICS ASA (GENT.OL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GENTIAN DIAGNOSTICS ASA (GENT.OL) Insider and Institutional Ownership to learn about the owners and their transactions.
- GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Chart to make your own analysis
- GENTIAN DIAGNOSTICS ASA (GENT.OL) Latest news and press-releases to stay up to date.
Does GENTIAN DIAGNOSTICS ASA (GENT.OL) stock pay dividends?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a dividend yield of 0.8%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of GENT.OL dividend history, reliability and sustainability.
What is the Price/Earnings (PE) ratio of GENTIAN DIAGNOSTICS ASA (GENT.OL)?
The PE ratio for GENTIAN DIAGNOSTICS ASA (GENT.OL) is 17.27. This is based on the reported non-GAAP earnings per share of 2.89 and the current share price of 49.9 NOK. Check the full fundamental report for a full analysis of the valuation metrics for GENT.OL.
GENT.OL Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to GENT.OL. When comparing the yearly performance of all stocks, GENT.OL is one of the better performing stocks in the market, outperforming 83.13% of all stocks.
GENT.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL. GENT.OL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
GENT.OL Financial Highlights
Over the last trailing twelve months GENT.OL reported a non-GAAP Earnings per Share(EPS) of 2.89. The EPS increased by 522.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 29.78% | ||
| ROA | 19.72% | ||
| ROE | 23.34% | ||
| Debt/Equity | 0.03 |
GENT.OL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to GENT.OL. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 76.24% and a revenue growth 33.11% for GENT.OL